A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation
ConclusionsOur data suggest that GLP-1RA do not affect tacrolimus levels or transplant outcomes in solid organ transplant (SOT) recipients in the short term. GLP-1RA also seem to be as effective in SOT recipients for glycemic control and weight loss as in the non-transplant population with diabetes.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Transplant | Insulin | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Prograf | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology | Weight Loss